Trials / Completed
CompletedNCT00913029
Evaluation of the iStent Versus Two Ocular Hypotensive Agents in Patients With Primary Open-angle Glaucoma (POAG)
A Prospective, Unmasked, Randomized Evaluation of the iStent Versus Two Ocular Hypotensive Agents in Patients With Primary Open-Angle Glaucoma
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 192 (actual)
- Sponsor
- Glaukos Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Prospective, unmasked, randomized evaluation of the iStent in patients with primary open-angle glaucoma. Patients will be randomized to one of two groups: 1) iStent, or 2) medication.
Detailed description
Two hundred patients will be enrolled in the study at up to 21 clinical sites; follow-up is through 1 year.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | iStent | iStent |
| DRUG | latanoprost/timolol | Combination latanoprost/timolol |
Timeline
- Start date
- 2009-05-01
- Primary completion
- 2012-09-01
- Completion
- 2012-09-01
- First posted
- 2009-06-03
- Last updated
- 2015-05-20
Locations
16 sites across 9 countries: Armenia, Austria, France, Germany, Greece, Italy, Poland, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT00913029. Inclusion in this directory is not an endorsement.